Thoracic Drainage Devices Market Size, Share, Growth and Forecast (2026 - 2036)

Thoracic Drainage Devices Market Forecast and Outlook By Fact.MR

• In 2025, the thoracic drainage devices market was valued at USD 0.7 billion.
• Based on Fact.MR analysis, demand for thoracic drainage devices is estimated to grow to USD 0.8 billion in 2026 and USD 1.3 billion by 2036.
• FACT.MR projects a CAGR of 5.0% during the forecast period.

Summary of Thoracic Drainage Devices Market

• Market Definition
  • Market covers pleural drainage catheters, kits, secured needles, and integrated thoracic drainage systems for pleural effusion management, post-surgical drainage, and ICU respiratory care across hospitals, ambulatory surgical centres, and specialty clinics globally.
• Demand Drivers
  • Rising cardiothoracic surgery volumes are increasing device demand. Each procedure requires pre- and post-operative drainage. This creates consistent per-case consumption.
  • Infection control protocols are becoming stricter. Hospitals are prioritising single-use devices. Disposable kits reduce cross-contamination risk. ICU settings are moving toward disposable-only procurement.
  • Respiratory disease burden is rising across Asia Pacific and Latin America. Conditions such as pleural effusion and pneumothorax are increasing. Non-surgical drainage demand is expanding. Public hospitals are scaling thoracic catheter procurement.
• Key Segments Analyzed
  • By Product: Thoracic Drainage Systems hold approximately 45% share in 2026, preferred for integrated post-operative management in cardiothoracic surgery centres.
  • By Application: Thoracic Surgeries & Pulmonology leads at approximately 40% share in 2026, driven by high per-procedure drainage device utilisation in thoracic surgical and pulmonology departments.
  • By End User: Hospitals hold approximately 60% share in 2026, anchored by large-volume procurement through group purchasing organizations for ICU, cardiothoracic surgery, and emergency medicine departments.
  • By Usability: Disposable Devices hold approximately 64% share in 2026, driven by infection control mandates and single-use procurement specifications in ICUs and post-surgical care environments.
  • By Drainage Type: Dry Suction Systems hold approximately 51% share in 2026, preferred for post-operative thoracic drainage due to lower risk of accidental fluid overflow and simpler nursing management.
  • By Geography: North America leads in revenue share, while Asia Pacific particularly India and China records the fastest volume growth through 2036.
• Analyst Opinion at FACT.MR
  • Shambhu Nath Jha, Principal Consultant at Fact.MR, opines, ‘CXOs will observe a clear market divide. High-acuity hospitals are adopting integrated dry suction and digital drainage systems. Cost-constrained facilities continue to rely on disposable catheter kits. Suppliers need dual-portfolio strategies to address both segments.’
• Strategic Implications
  • Prioritize integrated dry suction and digital drainage system development targeting high-volume cardiothoracic surgery centres in the United States and Germany, where premium procurement and multi-year hospital supply contracts provide stable revenue.
  • Invest in disposable thoracic drainage kit cost optimization for emerging market procurement. India and China public hospital tender volumes represent a high-growth opportunity for suppliers offering cost-efficient, infection-control-compliant single-use platforms.
  • Establish distributor partnerships with SUS-empanelled hospitals in Brazil and Ayushman Bharat-empanelled tertiary care centres in India to secure institutional placement in the fastest-growing emerging markets for thoracic drainage devices.
• Methodology
  • Market sizing uses device unit shipment volumes by product type, average selling prices by usability and drainage type, and procedure-level utilisation data from thoracic and cardiac surgical volume statistics.
  • Analysis incorporates infection control procurement benchmarks, hospital ICU bed expansion data, and regulatory clearance records from FDA, CE, CDSCO, and NMPA for thoracic drainage device approvals.
  • Forecasts incorporate surgical volume growth rates, disposable device adoption curves, reimbursement policy updates, and expert inputs from cardiothoracic surgery procurement directors across covered regions.

The market is projected to generate USD 0.5 billion in incremental revenue between 2026 and 2036. Growth is structurally underpinned by rising thoracic and cardiac surgical volumes and expanding ICU infrastructure. Infection control mandates sustaining disposable device preference and helium supply constraints on reusable platforms temper rapid volume acceleration in mature healthcare markets.

Hospital procurement is consolidating toward integrated thoracic drainage systems that combine drainage, suction, and monitoring in a single platform. ICU directors and cardiothoracic surgeons are specifying dry suction and digital systems for post-operative management. Suppliers without validated single-use drainage kits or regulatory-cleared digital drainage systems are losing placement in high-volume cardiothoracic surgery centre tenders.

India leads growth at 6.5% CAGR through 2036, driven by Ayushman Bharat hospital infrastructure expansion and rising thoracic surgery volumes at tertiary care centres. China follows at 6.2%, reflecting government-backed respiratory disease programme investment and domestic ICU bed capacity expansion. Brazil records 5.4%, supported by SUS emergency care procurement and improving trauma centre infrastructure. The United States grows at 4.8%, anchored by high cardiothoracic surgical volumes and FDA-cleared digital drainage system adoption. Germany posts 4.6%, supported by GKV reimbursement and rising cardiac procedure rates. Japan trails at 4.3%, where stable replacement demand from an aging surgical population defines the procurement cycle.

Segmental Analysis

Thoracic Drainage Devices Market Analysis by Product

Based on FACT.MR’s thoracic drainage devices market report, Thoracic Drainage Systems hold approximately 45% share in 2026. Integrated systems combining drainage chamber, suction regulation, and fluid management are the default specification for post-cardiothoracic surgery care, offering clinicians a single-unit solution that reduces setup time and error risk in high-acuity environments.

• Medtronic Portfolio Expansion: Medtronic plc expanded its thoracic drainage system product line in 2024, introducing an updated Thopaz+ digital drainage platform targeting cardiothoracic ICUs in the United States and Europe. The system features continuous flow monitoring and wireless data integration with hospital EMR systems [4].
• Becton Dickinson Catheter Launch: Becton Dickinson launched an updated pleural drainage catheter series in early 2025, incorporating antimicrobial-coated surfaces for infection risk reduction in long-term pleural drainage applications at specialty pulmonology centres [5].
• Drainage Kit Volume Growth: Disposable thoracic drainage kit procurement in public hospital tenders across India and Brazil expanded through 2024, driven by government infection control policy updates requiring single-use drainage components in ICU settings [3].

Thoracic Drainage Devices Market Analysis by Application

Based on FACT.MR’s thoracic drainage devices market report, Thoracic Surgeries & Pulmonology leads at approximately 40% share in 2026. High per-procedure device utilisation, mandatory post-operative pleural drainage requirements, and structured hospital procurement cycles sustain this segment’s volume dominance across all covered geographies.

• Getinge Partnership: Getinge AB signed supply agreements with cardiothoracic surgery programmes at multiple European hospital networks in 2024, linking thoracic drainage system procurement with its post-operative intensive care equipment portfolio for cardiac surgery ICUs [6].
• Teleflex Pulmonology Launch: Teleflex Incorporated introduced an updated pleural catheter system for outpatient pulmonology settings in early 2025, enabling tunnelled pleural catheter management for malignant effusion outside inpatient environments at certified specialty clinics [7].
• Emergency Medicine Adoption: Emergency medicine departments in U.S. Level I trauma centres expanded thoracic drainage device procurement through 2024, driven by rising pneumothorax incidence in trauma cases and updated ATLS guidelines recommending early chest tube insertion protocols [1].

Thoracic Drainage Devices Market Analysis by End User

Based on FACT.MR’s thoracic drainage devices market report, hospitals hold approximately 60% share in 2026. Cardiothoracic surgery departments, ICUs, and emergency medicine wards generate the highest per-facility device consumption volumes. Ambulatory surgical centres represent the fastest-growing end-user segment as outpatient thoracic procedures expand.

• Cook Group Hospital Procurement: Cook Group Incorporated secured multi-hospital supply contracts for thoracic drainage catheter kits across U.S. health system networks in 2024, covering both cardiac surgery departments and medical ICUs within integrated delivery network group purchasing agreements [8].
• Merit Medical ASC Expansion: Merit Medical Systems expanded its thoracic drainage product distribution to ambulatory surgical centres in the United States and Canada in early 2025, targeting outpatient video-assisted thoracoscopic surgery programmes with procedure-specific drainage kit configurations [9].
• Specialty Clinic Channel Growth: Specialty pulmonology and pleural disease clinics in the United Kingdom and Germany expanded thoracic catheter procurement through 2024, driven by NHS and GKV-funded outpatient pleural effusion management programme growth at respiratory medicine centres [6].

Thoracic Drainage Devices Market Analysis by Usability

Based on FACT.MR’s thoracic drainage devices market report, disposable devices hold approximately 64% share in 2026. Single-use thoracic drainage catheters and kits are the standard specification in ICUs and post-surgical care due to infection control requirements and regulatory pressure toward eliminating reprocessed device risk in high-acuity hospital environments.

• Smiths Group Single-Use Portfolio: Smiths Group plc expanded its single-use thoracic drainage catheter portfolio in 2024, targeting hospital infection control procurement committees in the United Kingdom and European markets with antimicrobial-coated disposable catheter lines for ICU and post-cardiac surgery applications.
• Vygon Disposable Kit Launch: Vygon SA introduced a comprehensive disposable thoracic drainage procedure kit in early 2025, bundling catheter, connector, and drainage chamber components for single-setup use in emergency medicine and ICU thoracic drainage procedures across European hospital markets.
• Reusable Device Decline: Reusable thoracic drainage system procurement declined in high-acuity Western European hospital settings through 2024 as infection prevention and control committees updated approved product lists to exclude reprocessed drainage chambers in post-surgical ICU protocols [2].

Thoracic Drainage Devices Market Analysis by Drainage Type

Based on FACT.MR’s thoracic drainage devices market report, dry suction systems hold approximately 51% share in 2026. Dry suction platforms eliminate fluid-filled water seal chambers, reducing nursing management complexity and accidental overflow risk in post-operative thoracic care.

• Medela Digital Drainage: Medela AG expanded its Thopaz digital dry suction drainage system distribution across European cardiothoracic surgery centres in 2024, reporting increased institutional adoption driven by documented post-operative air leak reduction and hospital length-of-stay benefits disclosed in peer-reviewed surgical outcomes studies.
• Heimlich Valve Adoption: Heimlich valve procurement for outpatient pneumothorax management expanded in NHS-funded ambulatory care settings in the United Kingdom in 2024–2025, supported by updated British Thoracic Society guidelines recommending Heimlich valves for stable secondary spontaneous pneumothorax managed outside inpatient wards.
• Wet Suction System Replacement: Wet suction system replacement by dry suction platforms accelerated across U.S. and German hospital cardiothoracic surgery units through 2024, as cost-benefit analyses in institutional procurement reviews demonstrated lower nursing intervention time and complication rates with digital dry suction systems.

Drivers, Restraints, and Opportunities

FACT.MR analysts observe the thoracic drainage devices market at USD 0.8 billion in 2026 reflects a procedure-volume-driven category shaped by rising cardiothoracic surgery rates and expanding ICU infrastructure.

Standard wet suction drainage systems face volume pressure in high-acuity hospital settings. Demand is shifting toward dry suction platforms and digitally integrated drainage systems that reduce nursing workload and post-operative complication risk.

• Cardiothoracic Surgical Volume Growth: Global cardiac surgery procedure volumes increased through 2024 and into 2025, particularly in Asia Pacific and Latin America. The Society of Thoracic Surgeons reported continued growth in coronary artery bypass and valve replacement procedures across U.S. centres in 2024.
• Infection Control Mandates and Disposable Adoption: The Centers for Disease Control and Prevention updated healthcare-associated infection prevention guidelines in 2024, reinforcing single-use device requirements for pleural drainage in ICU settings.
• Asia Pacific Respiratory Disease Burden: India and China recorded elevated rates of tuberculosis-related pleural effusion and community-acquired pneumonia requiring drainage in 2024, per WHO Global Tuberculosis Report data.

Regional Analysis

The thoracic drainage devices market is assessed across North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, covering 40+ countries with demand shaped by surgical procedure volumes, ICU infrastructure, infection control mandates, and public healthcare reimbursement structures. The full report offers market attractiveness analysis by region and country.

Source: Fact.MR (FACT.MR) analysis, based on proprietary forecasting model and primary research

North America Thoracic Drainage Devices Market Analysis

North America continues to anchor global demand for thoracic drainage devices. High surgical intensity supports consistent utilisation. ICU procurement remains organised and protocol-driven. Digital drainage systems are steadily gaining clinical acceptance.

• United States: Rising procedural volumes define the outlook in the United States, where the market grows at 4.8% CAGR through 2036. Cardiac and thoracic surgeries continue to expand across major centres. Reimbursement revisions are supporting outpatient catheter usage. Digital platforms are becoming standard in large hospital systems. Procurement is increasingly consolidated through national purchasing groups.

FACT.MR’s North America coverage includes the United States, Canada, and Mexico. It captures reimbursement dynamics, surgical trends, and procurement structures.

Europe Thoracic Drainage Devices Market Analysis

Europe operates within a highly structured regulatory and reimbursement environment. Clinical standards and CE compliance guide product adoption. Established suppliers maintain strong institutional relationships. Dry suction and disposable systems are advancing ahead of global averages.

• Germany: Procedure-driven demand supports steady growth in Germany at 4.6% CAGR through 2036. Public insurance frameworks ensure stable device funding. Minimally invasive techniques are increasing device utilisation. Clinical protocols are shifting toward dry suction systems. Hospitals are gradually upgrading legacy infrastructure.

FACT.MR’s analysis of the thoracic drainage devices market in Europe consists of country-wise assessment that includes Germany, France, the UK, Italy, Spain, and BENELUX. Readers can find reimbursement frameworks, surgical volume trends, and regulatory compliance benchmarks.

Asia Pacific Thoracic Drainage Devices Market Analysis

Asia Pacific is the fastest-growing region for thoracic drainage devices by volume. Government-funded hospital infrastructure expansion, rising respiratory disease burden, and increasing thoracic surgical capacity are primary demand drivers. Domestic manufacturers compete on price in public tenders while multinational suppliers target premium hospital procurement.

• China: Demand for thoracic drainage devices in China is projected to rise at 6.2% CAGR through 2036. ICU infrastructure is expanding rapidly. Public hospital procurement volumes are rising. Domestic manufacturers are scaling production. Regulatory approvals are enabling broader product access.

• Japan: Aging demographics shape demand patterns in Japan, where growth reaches 4.3% CAGR through 2036. Surgical volumes remain stable across cardiac centres. Replacement-driven procurement dominates. Digital systems are entering top-tier hospitals. Distribution networks remain well established.

• India: Healthcare access expansion defines growth in India at 6.5% CAGR through 2036. Public insurance schemes are increasing surgical coverage. Government hospitals are scaling device procurement. Infectious disease burden is supporting catheter demand. Private hospital investment is also rising.

FACT.MR’s analysis of the thoracic drainage devices market in Asia Pacific consists of country-wise assessment that includes China, Japan, India, South Korea, and ASEAN. Readers can find surgical volume data, procurement frameworks, and regulatory compliance benchmarks.

Competitive Aligners for Market Players

The thoracic drainage devices market does not behave like a single unified space. It is divided between high-value system providers and volume-driven disposable suppliers. Companies such as Medtronic plc and Becton, Dickinson and Company operate with strong institutional access. Their advantage lies in long-term hospital contracts and bundled product offerings. Players like Getinge AB and Smiths Group plc maintain visibility through critical care and surgical portfolios.

The basis of competition is shifting. Hospitals are no longer selecting devices purely on cost. Clinical workflow, ease of monitoring, and post-operative outcomes are becoming selection criteria. This is pushing demand toward dry suction and digital drainage platforms. Suppliers with limited presence in advanced systems are finding it harder to compete in large hospital tenders.

At the same time, a parallel price-sensitive segment continues to expand. Public hospitals and smaller facilities are focused on disposable kits. These buyers prioritise cost control and availability over advanced features. Regional manufacturers are active here, often undercutting global brands in tenders. Procurement behaviour is also evolving. Large hospital networks are centralising purchases. Decision-making is moving from individual departments to procurement committees. Contracts are structured around volume commitments and service reliability. Vendors are expected to support training and clinical integration, not just supply devices. The market is balancing two different expectations. Innovation is required to stay relevant in advanced care settings. Cost discipline is essential to compete in high-volume segments.

Key Players

• Medtronic plc
• Teleflex Incorporated
• Becton Dickinson (BD)
• Getinge AB
• Smiths Group plc
• Cook Group Incorporated
• Merit Medical Systems
• Vygon SA
• Medela AG

Bibliography

• [1] Society of Thoracic Surgeons. (2024). STS Annual Database Report: Coronary Artery Bypass, Valve Replacement, and Lung Resection Procedure Volumes and Post-Operative Drainage Device Utilisation at U.S. Cardiothoracic Surgery Centres. sts.org/resources/annual-report
• [2] Centers for Disease Control and Prevention. (2024). Healthcare-Associated Infection Prevention Guideline Update: Single-Use Device Requirements for Pleural and Mediastinal Drainage in Intensive Care Unit Settings. cdc.gov/hai/guidelines
• [3] World Health Organization. (2024). Global Tuberculosis Report 2024: Pleural Effusion Incidence, Treatment Rates, and Drainage Device Demand in High-Burden Countries Including India and China. who.int/publications/global-tuberculosis-report
• [4] Medtronic plc. (2024). Product Announcement: Thopaz+ Digital Thoracic Drainage System Expansion with EMR Integration for Cardiothoracic ICUs in the United States and Europe. medtronic.com/news
• [5] Becton Dickinson. (Early 2025). Product Launch: Antimicrobial-Coated Pleural Drainage Catheter Series for Long-Term Pleural Drainage at Specialty Pulmonology Centres. bd.com/newsroom
• [6] Getinge AB. (2024). Annual Report: Cardiothoracic Surgery Programme Supply Agreements and Post-Operative Intensive Care Equipment Portfolio Expansion Across European Hospital Networks. getinge.com/investor-relations
• [7] Teleflex Incorporated. (Early 2025). Product Launch: Tunnelled Pleural Catheter System for Outpatient Malignant Effusion Management at Certified Specialty Pulmonology Clinics. teleflex.com/news
• [8] Cook Group Incorporated. (2024). Corporate Announcement: Multi-Hospital Supply Contracts for Thoracic Drainage Catheter Kits Across U.S. Health System Integrated Delivery Networks and Group Purchasing Agreements. cookmedical.com/news
• [9] Merit Medical Systems. (Early 2025). Distribution Expansion: Thoracic Drainage Product Line Extended to U.S. and Canadian Ambulatory Surgical Centres for Outpatient VATS Programme Drainage Kit Supply. merit.com/news

This Report Addresses

• Strategic intelligence on thoracic drainage device demand across pleural catheters, drainage kits, secured needles, and integrated drainage systems for post-surgical, ICU, and pulmonology applications globally.
• Market forecast from USD 0.8 billion in 2026 to USD 1.3 billion by 2036, at a CAGR of 5.0%.
• Growth opportunity mapping across India Ayushman Bharat surgical procurement expansion, China ICU infrastructure investment, U.S. CMS reimbursement updates, Germany GKV product listing revisions, and Japan PMDA-cleared digital drainage system adoption.
• Segment analysis by product (catheters, kits, systems, needles), application (thoracic surgery, cardiac, ICU, infectious disease), end user (hospitals, ASCs, specialty clinics), usability (disposable vs reusable), and drainage type (dry suction, wet suction, Heimlich valves).
• Competitive analysis of Medtronic, Becton Dickinson, Getinge, Teleflex, Smiths Group, Cook Group, Merit Medical, Vygon, and Medela covering digital drainage platform depth, disposable kit portfolio breadth, and hospital GPO contract positioning.
• Regulatory analysis covering FDA 510(k) clearances, CE marking requirements, CDSCO quality standards, NMPA approvals, and reimbursement frameworks governing thoracic drainage device procurement across covered markets.
• Regulatory impact analysis covering infection control mandate updates from CDC, BTS guidelines, and national health ministry procurement specification revisions affecting disposable device adoption across hospital markets.
• Report delivered in PDF, Excel, and presentation formats, supported by primary interviews, surgical volume data, reimbursement records, and infection control procurement benchmarks.

Market Definition

Thoracic drainage devices are medical instruments used to remove air, blood, or fluid from the pleural or mediastinal space following thoracic and cardiac surgery or due to pathological conditions such as pneumothorax and pleural effusion.

Thoracic Drainage Devices Market Inclusions

Covers global and regional forecasts from 2026 to 2036. Includes product, application, end user, usability, and drainage type segments. Covers hospitals, ambulatory surgical centres, and specialty clinics. Includes device sales, drainage kit procurement, and system-level integrated platform revenues across all five geographic regions.

Thoracic Drainage Devices Market Exclusions

Excludes general surgical drains and wound drainage systems not designed for pleural or mediastinal use. Omits standalone suction pumps supplied without thoracic drainage components.

Thoracic Drainage Devices Market Research Methodology

• Primary Research
  • Interviews with cardiothoracic surgery procurement managers, ICU medical directors, pulmonology department heads, and hospital supply chain administrators across North America, Europe, Asia Pacific, and Latin America.
• Desk Research
  • Uses Medtronic, Becton Dickinson, Getinge AB, and Teleflex Incorporated disclosure data. Includes thoracic surgical volume statistics, ICU bed capacity data, and infection control procurement benchmarks from 2024–2025.
• Market-Sizing and Forecasting
  • Hybrid bottom-up model using device unit volumes by product type and end-user segment, average selling prices by usability and drainage type, and procedure-level utilisation rates. Top-down validation against global surgical device market benchmarks.
• Data Validation and Update Cycle
  • Validated using OEM revenue disclosures, surgical volume statistics from national health ministries, and hospital procurement benchmarks. Cross-checked with infection control procurement audits and expert interviews. Updated annually.